Metoprolol CR/XL in postmyocardial infarction patients with chronic heart failure: Experiences from MERIT-HF

American Heart Journal

Volumn 146, Issue 4, 2003, Pages 721-728

  Jánosi, András ^a   Ghali, Jalal K ^b   Herlitz, Johan ^c   Czuriga, István ^d   Klibaner, Michael ^e   Wikstrand, John ^f,g   Hjalmarson, Ake ^c  

^a Szent János Teaching Hospital   (Hungary)

^b Cardiac Centers of Louisiana   (United States)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^d UNIVERSITY OF DEBRECEN   (Hungary)

^e ASTRAZENECA   (United Kingdom)

^f ASTRAZENECA R AND D   (Sweden)

^g UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; METOPROLOL; METOPROLOL SUCCINATE; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ADULT; AGED; ANALYTIC METHOD; ANAMNESIS; ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG EFFECT; DRUG SCREENING; EXPERIENCE; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HOSPITALIZATION; HUMAN; MALE; MORTALITY; OUTCOMES RESEARCH; PATIENT; POPULATION RESEARCH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUDDEN DEATH; SUSTAINED DRUG RELEASE; SYMPTOM;

EID: 0142088811     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(03)00163-7     Document Type: Article

References (23)

1. Hjalmarson Ȧ, Elmfeldt D, Herlitz J, et al. Effect on mortality of metoprolol in acute myocardial infarction: a double blind randomized trial. Lancet 1981;2:823-7.
2. The Norwegian Multicenter Study Group. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Eng J Med 1981;2304:801-7.
3. The BHAT Research Group. A randomized trial of propranolol in patients with acute myocardial infarction: I: mortality results. JAMA 1982;247:1707-14.
4. Herlitz J, Hartford M, Pennert K, et al. The Göteborg Metoprolol trial: clinical observations. Am J Cardiol 1984;53:37-45D.
5. Yusuf S, Peto R, Lewis J, et al. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 1985;17:335-71.
6. CIBIS II Investigators and Committees. The cardiac insufficiency bisoprolol study II (CIBIS II). Lancet 1999;353:9-13.
7. MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF). Lancet 1999;353:2001-7.
8. Hjalmarson Ȧ, Goldstein S, Fagerberg B, et al. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT HF). JAMA 2000;283:1295-302.
9. Packer M, Coats AJS, Fowler MB, et al. Effect of carvedilol on survival in severe chronic heart failure. N Eng J Med 2001;344:1651-8.
10. The CAPRICORN Investigators. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomized trial. Lancet 2001;257:1385-90.
11. Olsson G, Wikstrand J, Warnold I, et al. Metoprolol-induced reduction in post infarction mortality: pooled results from five double-blind randomized trials. Eur Heart J 1992;13:28-32.
12. Herlitz J, Waagstein F, Lindqvist J, et al. Effect of metoprolol on the prognosis for patients with suspected acute myocardial infarction and indirect signs of congestive heart failure (a subgroup analysis of the Göteborg metoprolol trial). Am J Cardiol 1997;80:40-4J.
13. Goldstein S, Fagerberg B, Hjalmarson Ȧ, et al. Metoprolol controlled release/extended release in patients with severe heart failure: analysis of the experience in the MERIT-HF study. J Am Coll Cardiol 2001;38:932-8.
14. Wikstrand J. MERIT-HF: description of the trial. Basic Res Cardiology 2000;95(1 Suppl):I/90-7.
15. Gundersen T. Influence of heart size on mortality and reinfarction in patients treated with timolol after myocardial infarction. Br Heart J 1983;50:135-9.
16. Chadda K, Goldstein S, Byington R, et al. Effect of propranolol after acute myocardial infarction in patients with congestive heart failure. Circulation 1986;73:503-10.
17. Wikstrand J, Kendall M. The role of beta receptor blockade in preventing sudden death. Eur Heart J 1992;13(Suppl D):111-20.
18. The SOLVD investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:293-302.
19. Pfeffer MA, Braunwald E, Moyé LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the survival and ventricular enlargement trial. N Engl J Med 1992;327:669-77.
20. Garg RG, Yusuf S. Overview of randomized trials of angiotensin converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA 1995;273:1450-6.
21. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83.
22. Marciniak TA, Ellerbeck EF, Radford MJ, et al. Improving the quality of care for medicare patients with acute myocardial infarction. JAMA 1998;279:1351-7.
23. Gottlieb SS, McCarter RJ, Vogel RA. Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. N Engl J Med 1998;339:489-97.